Specifically, TRPV6 is a highly Ca2+-selective channel [23–26] and its activity is also known to be modulated by oestrogen, progesterone, tamoxifen and vitamin D, affecting proliferation and survival of cancer cells [27]. The gene discussed is TRPV6; the disease is cancer.